Total Payments
$8,981
2024 Payments
$327.45
Companies
36
Transactions
382
Medicare Patients
8,913
Medicare Billing
$816,382
Payment Breakdown by Category
Food & Beverage$7,690 (85.6%)
Travel$1,291 (14.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,690 | 379 | 85.6% |
| Travel and Lodging | $1,291 | 3 | 14.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $2,460 | 42 | $0 (2020) |
| Abbott Laboratories | $925.05 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $677.45 | 40 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $567.15 | 39 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $551.78 | 34 | $0 (2023) |
| Amgen Inc. | $518.63 | 33 | $0 (2023) |
| Teleflex LLC | $462.67 | 10 | $0 (2024) |
| Medtronic, Inc. | $382.61 | 22 | $0 (2023) |
| ABIOMED | $308.54 | 4 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $303.27 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $327.45 | 12 | Teleflex LLC ($85.86) |
| 2023 | $1,159 | 51 | Teleflex LLC ($345.53) |
| 2022 | $1,004 | 56 | Novartis Pharmaceuticals Corporation ($250.38) |
| 2021 | $686.82 | 38 | Medtronic, Inc. ($186.26) |
| 2020 | $696.62 | 41 | Medtronic Vascular, Inc. ($149.23) |
| 2019 | $709.30 | 42 | AstraZeneca Pharmaceuticals LP ($227.20) |
| 2018 | $1,140 | 60 | Medtronic Vascular, Inc. ($247.28) |
| 2017 | $3,258 | 82 | Medtronic Vascular, Inc. ($2,035) |
All Payment Transactions
382 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $19.01 | General |
| Category: Oncology | ||||||
| 12/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: CARDIOLOGY | ||||||
| 11/14/2024 | Philips North America LLC | (CK6) Holter (Device) | Food and Beverage | Cash or cash equivalent | $22.62 | General |
| Category: Medical Device | ||||||
| 11/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.81 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/20/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Vascular | ||||||
| 07/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.77 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/30/2024 | Teleflex LLC | MANTA (Device) | Food and Beverage | In-kind items and services | $43.18 | General |
| Category: INTERVENTIONAL ACCESS | ||||||
| 05/30/2024 | Teleflex LLC | TRAPLINER (Device) | Food and Beverage | In-kind items and services | $42.68 | General |
| Category: INTERVENTIONAL ACCESS | ||||||
| 03/12/2024 | Abbott Laboratories | XIENCE SIERRA (Device) | Food and Beverage | In-kind items and services | $46.23 | General |
| Category: Vascular | ||||||
| 02/16/2024 | Boston Scientific Corporation | EkoSonic (Device) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: EkoSonic_PI | ||||||
| 10/20/2023 | Teleflex LLC | SUPERCROSS (Device) | Food and Beverage | In-kind items and services | $107.19 | General |
| Category: Interventional Access | ||||||
| 10/19/2023 | Medtronic, Inc. | TYRX (Device) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Antibacterial Mesh | ||||||
| 08/30/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Cardiology | ||||||
| 08/28/2023 | Teleflex LLC | SUPERCROSS (Device) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: Interventional Access | ||||||
| 08/24/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/22/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $0.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/16/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.47 | General |
| Category: Cardiovascular | ||||||
| 08/15/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/09/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Cardiology | ||||||
| 08/04/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,643 | 3,605 | $805,918 | $217,396 |
| 2022 | 19 | 2,002 | 2,896 | $748,266 | $211,020 |
| 2021 | 23 | 2,202 | 3,103 | $790,777 | $225,984 |
| 2020 | 27 | 2,066 | 2,560 | $590,216 | $161,982 |
Total Patients
8,913
Total Services
12,164
Medicare Billing
$816,382
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 447 | 655 | $210,012 | $56,474 | 26.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 63 | 63 | $82,572 | $21,399 | 25.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 34 | 41 | $52,510 | $17,975 | 34.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 124 | 276 | $28,942 | $16,933 | 58.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 107 | 107 | $74,566 | $14,703 | 19.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 104 | 110 | $63,532 | $14,587 | 23.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 76 | 77 | $57,029 | $13,905 | 24.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 62 | 121 | $16,325 | $11,122 | 68.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 49 | 196 | $30,936 | $7,791 | 25.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 491 | 743 | $44,497 | $7,673 | 17.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 143 | 144 | $30,658 | $7,465 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $27,145 | $6,294 | 23.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 42 | $18,052 | $5,280 | 29.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 498 | 611 | $17,108 | $3,765 | 22.0% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 13 | 14 | $11,790 | $3,033 | 25.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 61 | 61 | $17,062 | $2,982 | 17.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 17 | $5,085 | $1,592 | 31.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 12 | $4,696 | $1,161 | 24.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 104 | 113 | $4,068 | $1,095 | 26.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 13 | 13 | $3,131 | $778.05 | 24.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 33 | 33 | $2,868 | $643.83 | 22.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 18 | 18 | $1,313 | $298.80 | 22.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 18 | 18 | $864.00 | $197.28 | 22.8% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 29 | 29 | $725.00 | $162.11 | 22.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 36 | 36 | $432.00 | $86.76 | 20.1% |
About Dr. Jun Chung, M.D
Dr. Jun Chung, M.D is a Interventional Cardiology healthcare provider based in Suffolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295758191.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jun Chung, M.D has received a total of $8,981 in payments from pharmaceutical and medical device companies, with $327.45 received in 2024. These payments were reported across 382 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,690).
As a Medicare-enrolled provider, Chung has provided services to 8,913 Medicare beneficiaries, totaling 12,164 services with total Medicare billing of $816,382. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Suffolk, VA
- Active Since 07/25/2006
- Last Updated 02/28/2011
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1295758191
Products in Payments
- ENTRESTO (Drug) $556.18
- XARELTO (Drug) $551.78
- BRILINTA (Drug) $496.37
- Impella (Device) $308.54
- LifeVest (Device) $303.27
- Repatha (Biological) $282.63
- Corlanor (Drug) $236.00
- Absorb GT1 (Device) $219.52
- ELIQUIS (Drug) $203.61
- Xience Sierra Coronary Stent System (Device) $186.92
- Reveal LINQ (Device) $180.04
- AZUR (Device) $150.36
- Xience Alpine cornary stent system (Device) $140.00
- SUPERCROSS (Device) $137.53
- LEQVIO (Drug) $121.27
- Micra (Device) $113.01
- Visia AF (Device) $107.96
- Advisa (Device) $105.97
- MANTA (Device) $99.45
- JARDIANCE (Drug) $90.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.